From strains to finished products, Biose Industrie manufactures microbiome solutions for pharmaceutical and non-pharmaceutical markets, supporting projects from development to commercial supply.
Biose Industrie is a specialised microbiome CDMO supporting biotechnology, pharmaceutical, and consumer-focused companies across Live Biotherapeutic Products (LBPs), Next-Generation Probiotics (NGPs), consumer health, consumer care, and cosmetics.
We combine deep aerobic and anaerobic microbiology expertise, industrial scale, and robust GMP quality systems to take projects from development to commercialisation.
Our vision is to build a future where the potential of micro-organisms strengthens and enhances health and well-being, across regulated pharmaceutical applications and everyday consumer solutions.
A pioneer in pharmaceutical microbiology since 1951, Biose Industrie operates two complementary businesses serving a wide range of industries:
An international CDMO specialised in Live Biotherapeutic Products (LBPs) and Next-Generation Probiotics (NGPs), from process development to GMP drug product manufacturing.
Supplier of microbiome-based ingredients and finished products under private label for the health, nutrition, wellness, and cosmetic markets.
Our mission is to contribute to the success and satisfaction of our clients by delivering micro-organism-based solutions — ingredients, finished products, and dedicated developments — driven by scientific excellence, industrial performance, and anticipation of regulatory and market evolutions.
